Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 107-110

  De Ridder, Marleen C ^a   Van Der Plas, Arnout J ^a   Erpelinck Verkschueren, Claudia A J ^a   Löwenberg, Bob ^a   Jansen, Joop H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Dexamethasone

Indexed keywords

DEXAMETHASONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETINOIC ACID SYNDROME;

ANTIGENS, CD18; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, NORTHERN; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DEXAMETHASONE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; THROMBOMODULIN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032838302     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01481.x     Document Type: Article

References (12)

1. Avvisati, G., Lo Coco, F., Diverio, D., Falda, M., Ferrara, F., Lazzarino, M., Russo, D., Petti, M.C. & Mandelli, F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto (Gimema) pilot study. Blood, 88, 1390-1398.
2. De Botton, S., Dombret, H., Sanz, M., Miguel, J.S., Caillot, D., Zittoun, R., Gardembas, M., Stamatoulas, A., Conde, E., Guerci, A., Gardin, C., Geiser, K., Makhoul, D.C., Reman, O., de la Serna, J., Lefrere, F., Chomienne, C., Chastang, C., Degos, L. & Fenaux, P. (1998) Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukaemia. The European APL Group. Blood, 92, 2712-2718.
3. Dyck, J.A., Maul, G.G., Miller, WH., Jr, Chen, J.D., Kakizuka, A. & Evans, R.M. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76, 333-343.
4. Fenaux, P. & De Botton, S. (1998) Retinoic acid syndrome: recognition, prevention and management. Drug Safety, 18, 273-279.
5. Glasser, L. & Fiederlein, R.L. (1987) Functional differentiation of normal human neutrophils. Blood, 33, 937-944.
6. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F. & Berger, R. (1991) NB4, a maturation inducible cell line with t(15:17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77, 1080-1086.
7. Lo Coco, F., Nervi, C., Avvisati, G. & Mandelli, F. (1998) Acute promyelocytic leukemia: a curable disease. Leukemia, 12, 1866-1880.
8. Ramdas, J. & Harmon, J.M. (1998) Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukaemic T cells. Endocrinology, 139, 3813-3821.
9. Rowley, J., Golomb, H.M. & Dougherty, C. (1977) 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet, i, 549-550.
10. Tallman, M.S., Andersen, J.W. & Schiffer, C.A. (1997) All-transretinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1021-1028.
11. Tallman, M.S. & Kwaan, H.C. (1992) Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood, 79, 543-553.
12. Weis, K., Rambaud, S., Lavau, C., Jansen, J.H., Carvalho, T., Carmo-Fonseca, M., Lamond, A. & Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell, 76, 345-356.